Burfiralimab Biosimilar - Research Grade

Human

VIM

5mg/ml

Human IgG4 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH2784

P08670

Blue ice

Vimentin (VIM) is an intermediate-filament protein whose surface and extracellular forms are linked to inflammation and tumour biology, a target across diverse research fields. This recombinant anti-human VIM monoclonal is an unconjugated, non-therapeutic analog of burfiralimab, supplied for research use only (RUO). It is manufactured to in vivo standards, carries low endotoxin, and is offered in scalable milligram (mg) to gram (g) quantities for bulk and high-throughput laboratories. Use it in functional assays, vimentin-binding and cell-interaction studies, reproducible controls, and in vivo disease models, with the lot-to-lot consistency needed for heavy-usage research.

Detects human VIM

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

4 weeks